RE:PatienceGreat insight Danny. Hypothetical question: I was thinking the same thing as you. IF/WHEN Ifenprodyl is successful in its treatments, I think it will get offer after offer for a buyout of the rights to it. I'm guessing around 1 billion alone just for IPF. With a small company like algernon, it would be very hard to turn down. My question is, what will happen to share price when or if this happens? It happend to fit bit as a whole last year with apple, and they continued to trade under same name. Any experience with this?